Jiangxi Synergy Pharmaceutical Co., Ltd. Stock: price and insider trades · China
同和药业
1 insider bought €86k of shares over the last 90 days, the latest by 庞正伟, filed 28 Sept 2026.
Jiangxi Synergy Pharmaceutical Co., Ltd.: what insiders have been doing
Jiangxi Synergy Pharmaceutical Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). Over the twelve months to 7 November 2026, 1 filing were filed, from 1 insider.
The flow runs one way only: 1 insider bought (1 purchase totalling €86k) and nobody sold on the market. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a purchase of €86k from 庞正伟, disclosed on 28 September 2026. Among those who bought: 1 board member.
The clock since the last published purchase (28 September 2026) now reads 41 days.
With 1 filing in twelve months, the company is quieter than the median of 2 filings across the 522 companies we follow on the same exchange. The full history, which starts in 2021, counts 14 purchases against no sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -5.5%Entry CN¥7.09 · Close 05 Nov 2026 CN¥6.70
- +32.8%Entry CN¥12.19 · Close at T+365 CN¥16.18
- +67.0%Entry CN¥10.93 · Close at T+365 CN¥18.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 94,300 shares@ CN¥53.59432.9% of flowA股XSHESZSE:273000001605040100Canonical exit: 27 Dec 2026 (T+90)
- 723,800 shares47.5% of flowA股XSHESZSE:173000005346049100Canonical exit: 9 Mar 2022 (T+90)
- 341,900 shares21.9% of flowA股XSHESZSE:173000005150958140Canonical exit: 8 Mar 2022 (T+90)
- 87,600 shares5.4% of flowA股XSHESZSE:173000005146928030Canonical exit: 7 Mar 2022 (T+90)
- 118,000 shares9.9% of flowA股XSHESZSE:173000005146847070Canonical exit: 7 Mar 2022 (T+90)
- 240,320 shares20.4% of flowA股XSHESZSE:173000005142443650Canonical exit: 6 Mar 2022 (T+90)
- 360,000 shares30.6% of flowA股XSHESZSE:173000005130234340Canonical exit: 2 Mar 2022 (T+90)
- 39,500 shares2.9% of flowA股XSHESZSE:173000005038892640Canonical exit: 1 Feb 2022 (T+90)
- 423,600 shares22.5% of flowA股XSHESZSE:173000005129698200Canonical exit: 23 Dec 2021 (T+90)
- 50,000 shares2.6% of flowA股XSHESZSE:173000004905057730Canonical exit: 22 Dec 2021 (T+90)
- 300,000 shares21.3% of flowA股XSHESZSE:173000004818779360Canonical exit: 9 Dec 2021 (T+90)
- 200,000 shares14.8% of flowA股XSHESZSE:173000004799263680Canonical exit: 8 Dec 2021 (T+90)
- 300,000 shares100.0% of flowA股XSHESZSE:173000004441833100Canonical exit: 24 Aug 2021 (T+90)
- 949,400 shares100.0% of flowA股XSHESZSE:173000004436315800Canonical exit: 22 Aug 2021 (T+90)
14 of 14 declarations
About Jiangxi Synergy Pharmaceutical Co., Ltd.
Tonghua Dongbao Pharmaceutical Co., Ltd. is a company in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of innovative medicines.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
